107 related articles for article (PubMed ID: 16080486)
1. Sulfotransferase1A1 and risk of postmenopausal breast cancer.
Jerevall PL; Ahmadi A; Bergman M; Stål O; Wingren S
Anticancer Res; 2005; 25(3c):2515-7. PubMed ID: 16080486
[TBL] [Abstract][Full Text] [Related]
2. [The association of sulfotransferase1A1 His allele and breast cancer in Han ethnic Chinese women].
Han DF; Zhou X; Hu MB; Wang CH; Xie W; Zheng F; Liu F
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1759-63. PubMed ID: 14642079
[TBL] [Abstract][Full Text] [Related]
3. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.
Zheng W; Xie D; Cerhan JR; Sellers TA; Wen W; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):89-94. PubMed ID: 11219777
[TBL] [Abstract][Full Text] [Related]
4. Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer.
Seth P; Lunetta KL; Bell DW; Gray H; Nasser SM; Rhei E; Kaelin CM; Iglehart DJ; Marks JR; Garber JE; Haber DA; Polyak K
Cancer Res; 2000 Dec; 60(24):6859-63. PubMed ID: 11156380
[TBL] [Abstract][Full Text] [Related]
5. Sulfotransferase 1A1 polymorphism and gastric cancer risk: a pilot case-control study.
Boccia S; Persiani R; La Torre G; Rausei S; Arzani D; Gianfagna F; Romano-Spica V; D'Ugo D; Ricciardi G
Cancer Lett; 2005 Nov; 229(2):235-43. PubMed ID: 16137826
[TBL] [Abstract][Full Text] [Related]
6. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
7. The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects.
Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
Breast Cancer Res Treat; 2011 Jan; 125(1):215-9. PubMed ID: 20505990
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer.
Wegman P; Elingarami S; Carstensen J; Stål O; Nordenskjöld B; Wingren S
Breast Cancer Res; 2007; 9(1):R7. PubMed ID: 17244352
[TBL] [Abstract][Full Text] [Related]
9. Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinoma.
Rouprêt M; Cancel-Tassin G; Comperat E; Fromont G; Sibony M; Molinié V; Allory Y; Triau S; Champigneulle J; Gaffory C; Larré S; de la Taille A; Richard F; Hamdy FC; Cussenot O
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2500-3. PubMed ID: 18006944
[TBL] [Abstract][Full Text] [Related]
10. [Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women].
Shatalova EG; Loginov VI; Braga EA; Kazubskaia TP; Sudomoina MA; Blanchard RL; Favorova OO
Mol Biol (Mosk); 2006; 40(2):263-70. PubMed ID: 16637266
[TBL] [Abstract][Full Text] [Related]
11. SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case-control study.
Lilla C; Risch A; Kropp S; Chang-Claude J
Breast Cancer Res; 2005; 7(2):R229-37. PubMed ID: 15743503
[TBL] [Abstract][Full Text] [Related]
12. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
[TBL] [Abstract][Full Text] [Related]
13. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
[TBL] [Abstract][Full Text] [Related]
14. Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy.
Grabinski JL; Smith LS; Chisholm GB; Drengler R; Rodriguez GI; Lang AS; Kalter SP; Garner AM; Fichtel LM; Hollsten J; Pollock BH; Kuhn JG
Breast Cancer Res Treat; 2006 Jan; 95(1):13-6. PubMed ID: 16317586
[TBL] [Abstract][Full Text] [Related]
15. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO
Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725
[TBL] [Abstract][Full Text] [Related]
16. [A case-control study on the association between the genetic polymorphism of sulfotransferase 1A1, diet and susceptibility of colorectal cancer].
Chen K; Fan CH; Jin MJ; Song L; Xu H; He HQ; Tong F
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):670-3. PubMed ID: 17274372
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
Naidu R; Yip CH; Taib NA
Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants of the sulfotransferase 1A1 and breast cancer risk.
Langsenlehner U; Krippl P; Renner W; Yazdani-Biuki B; Eder T; Wolf G; Wascher TC; Paulweber B; Weitzer W; Samonigg H
Breast Cancer Res Treat; 2004 Sep; 87(1):19-22. PubMed ID: 15377847
[TBL] [Abstract][Full Text] [Related]
20. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
